“…Two types of hyperthermia depending on the stimulus used as a trigger, i.e ., optical or magnetic properties activated nanoheating agents. Magnetic hyperthermia (MHT) utilizes heat dissipation by MNPs to kill tumor cells when under an alternating magnetic field (AMF), − while photothermal therapy (PTT) employs photothermal agents that are activated by near-infrared laser (NIR) irradiation. − However, both magnetic hyperthermia and photothermal therapy have their limitations. , For instance, highly concentrated intratumoral injections of magnetic nanoparticles are required to compensate the low specific loss power (SLP) under low magnetic field intensity for the MHT, the real-time temperature monitoring is invasive thermometry, and the nanoparticles distribute non-uniformly within the tumor . Therefore, enhancing SLP value through modifications in the material properties, size, shape, and aggregation state of magnetic nanoparticles emerges as the pivotal factor for augmenting the effectiveness of magnetic hyperthermia. − In PTT, high-power laser exposure can damage surrounding healthy tissue, and some nanoparticles (gold and silver) used are not FDA-approved materials and may not meet biosafety requirements .…”